News Feeds || Alumni Network || Research Portal || Contact us || Mandatory Disclosure
Copyright 2009-10. Haldia Institute Of Technology I.C.A.R.E. Complex, H.I.T. Campus Hatiberia P.O: Debhog Dist: Midnapore(E), West Bengal, India. PIN : 721657
PHONE : (+913224)252900(BOARD), 252850 FAX : (+913224)252800, 253062
|
Swine Flu Update from all the department's
Summary: Issued by all departments for students Average User Rating:
|
| 24 SEPTEMBER 2009 | GENEVA --
Regulatory authorities have licensed pandemic vaccines in
Australia, China and the United States of America, soon to be
followed by Japan and several countries in Europe. The length of
the approval process depends on factors such as each country's
regulatory pathway, the type of vaccine being licensed, and the
stage of manufacturers' readiness to submit appropriate
information to regulatory authorities. Availability in developing countries Last week, donations of pandemic vaccines for use in developing countries were announced by the United States of America, in concert with Australia, Brazil, France, Italy, New Zealand, Norway, Switzerland and the United Kingdom. Similar support from additional countries is anticipated and warmly welcomed. WHO will be coordinating the distribution of these donated vaccines. Earlier this year, WHO conducted surveys with its regional and country offices to identify countries that will not have pandemic vaccines unless supplies are donated. Teams with expertise in field operations, vaccines, and the logistics of their distribution are now working in the JW Lee Centre for Strategic Health Operations (the SHOC room). Initially, they will be distributing an estimated 300 million doses of vaccine to more than 90 countries. Distribution of the first batches of donated vaccines is expected to begin in November. WHO continues to recommend that health workers be given high priority for early vaccination. 
(Extracted from WHO website. Permalink at WHO:
Click here) |
